These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27259245)

  • 21. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JD-02, a novel Hsp90 inhibitor, induces ROS/SRC axis-dependent cytoprotective autophagy in colorectal cancer cells.
    Lan N; Su Y; Zeng Q; Zhou P; Hu Y; Zhang Z; Wang Y; Liu K
    Mol Carcinog; 2024 Jun; 63(6):1038-1050. PubMed ID: 38411361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin.
    Fedier A; Stuedli A; Fink D
    Int J Oncol; 2005 Dec; 27(6):1697-705. PubMed ID: 16273226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.
    Akasaka H; Mizushina Y; Yoshida K; Ejima Y; Mukumoto N; Wang T; Inubushi S; Nakayama M; Wakahara Y; Sasaki R
    Radiat Oncol; 2016 Nov; 11(1):153. PubMed ID: 27876069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.
    Maggiorella L; Deutsch E; Frascogna V; Chavaudra N; Jeanson L; Milliat F; Eschwege F; Bourhis J
    Cancer Res; 2003 May; 63(10):2513-7. PubMed ID: 12750274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells.
    Rae C; Mairs RJ
    Int J Radiat Biol; 2017 Feb; 93(2):194-203. PubMed ID: 27600766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
    Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
    Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical evaluation of radiosensitizing activity of Pluronic block copolymers.
    Perera RH; Patel R; Wu H; Gangolli M; Traughber B; Oleinick N; Exner AA
    Int J Radiat Biol; 2013 Oct; 89(10):801-12. PubMed ID: 23631609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond.
    Orth M; Albrecht V; Seidl K; Kinzel L; Unger K; Hess J; Kreutzer L; Sun N; Stegen B; Nieto A; Maas J; Winssinger N; Friedl AA; Walch AK; Belka C; Zitzelsberger H; Niyazi M; Lauber K
    Front Oncol; 2021; 11():612354. PubMed ID: 33816244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of hsp90 compromises the DNA damage response to radiation.
    Dote H; Burgan WE; Camphausen K; Tofilon PJ
    Cancer Res; 2006 Sep; 66(18):9211-20. PubMed ID: 16982765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
    Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1015-22. PubMed ID: 25205430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma.
    Kim EH; Kim MS; Lee KH; Koh JS; Jung WG; Kong CB
    Oncotarget; 2016 Oct; 7(43):70869-70880. PubMed ID: 27765919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma.
    Steinmann S; Gali-Muhtasib H; Huebner K; Al-Halabi R; Abou Merhi R; Aman P; Agaimy A; Haller F; Schneider-Stock R
    Cancer Lett; 2015 Oct; 367(2):147-56. PubMed ID: 26225840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells.
    Spiegelberg D; Dascalu A; Mortensen AC; Abramenkovs A; Kuku G; Nestor M; Stenerlöw B
    Oncotarget; 2015 Nov; 6(34):35652-66. PubMed ID: 26452257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
    Wang L; Long L; Wang W; Liang Z
    J Pharmacol Sci; 2015 Dec; 129(4):216-25. PubMed ID: 26698406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
    Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
    Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells.
    Ma H; Bi J; Liu T; Ke Y; Zhang S; Zhang T
    Oncol Rep; 2015 Mar; 33(3):1161-70. PubMed ID: 25572529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
    Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y
    Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.